Anjli Kukreja is the Head of Experimental Sciences for Inflammation Experimental Medicine at Boehringer Ingelheim. A PhD graduate from the University of Cambridge, she is a biologist specializing in early drug discovery, clinical biomarker strategy, and developing therapies for rare diseases and oncology.
She holds a patent for biomarker proteins related to Atypical Hemolytic Uremic Syndrome (aHUS), highlighting her innovative work in the field.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.